Terms: = Liver cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037
5584 results:
1. The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -CLEAP 004 study.
Yang CX; Pan YX; Ye F; Zhu XD; Xue J; Li X; Yuan ZG; Zhang L; Xu L; Chen YJ; Wang NY; Sun HC; Liu XF;
Front Immunol; 2024; 15():1310239. PubMed ID: 38711515
[TBL] [Abstract] [Full Text] [Related]
2. Expression of Fascin-1 and its diagnostic value in liver cancer.
Lu SP; Jiang LJ; Wang Y; Shao JK; Du ZQ; Huang BF; Wang CQ
Sci Rep; 2024 May; 14(1):10049. PubMed ID: 38698008
[TBL] [Abstract] [Full Text] [Related]
3. Circulating fatty acids and risk of hepatocellular carcinoma and chronic liver disease mortality in the UK Biobank.
Liu Z; Huang H; Xie J; Xu Y; Xu C
Nat Commun; 2024 May; 15(1):3707. PubMed ID: 38697980
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with endoplasmic reticulum stress, lipid metabolism, and liver metastasis in pancreatic cancer.
Liu X; Ren B; Fang Y; Ren J; Wang X; Gu M; Zhou F; Xiao R; Luo X; You L; Zhao Y
J Transl Med; 2024 Apr; 22(1):393. PubMed ID: 38685045
[TBL] [Abstract] [Full Text] [Related]
5. Quercetin Impairs the Growth of Uveal Melanoma Cells by Interfering with Glucose Uptake and Metabolism.
Tura A; Herfs V; Maaßen T; Zuo H; Vardanyan S; Prasuhn M; Ranjbar M; Kakkassery V; Grisanti S
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673877
[TBL] [Abstract] [Full Text] [Related]
6. REPeated mAgnetic resonance Image-guided stereotactic body Radiotherapy (MRIg-reSBRT) for oligometastatic patients: REPAIR, a mono-institutional retrospective study.
Chiloiro G; Panza G; Boldrini L; Romano A; Placidi L; Nardini M; Galetto M; Votta C; Campitelli M; Cellini F; Massaccesi M; Gambacorta MA
Radiat Oncol; 2024 Apr; 19(1):52. PubMed ID: 38671526
[TBL] [Abstract] [Full Text] [Related]
7. Non-small cell lung cancer and immune checkpoint inhibitor therapy: does non-alcoholic fatty liver disease have an effect?
Li Y; Gong B; Guo Y; Liu W; Chen C; Jiang S; Pan F; Song J; Yang L; Zhou G
BMC Cancer; 2024 Apr; 24(1):535. PubMed ID: 38671373
[TBL] [Abstract] [Full Text] [Related]
8. Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system.
Wei Q; Mease PJ; Chiorean M; Iles-Shih L; Matos WF; Baumgartner A; Molani S; Hwang YM; Belhu B; Ralevski A; Hadlock J
Lancet Digit Health; 2024 May; 6(5):e309-e322. PubMed ID: 38670740
[TBL] [Abstract] [Full Text] [Related]
9. liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohort.
Korenblik R; Heil J; Smits J; James S; Olij B; Bechstein WO; Bemelmans MHA; Binkert CA; Breitenstein S; Williams M; Detry O; Dewulf MJL; Dili A; Grochola LF; Grote J; Heise D; Kalil JA; Metrakos P; Neumann UP; Pappas SG; Pennetta F; Schnitzbauer AA; Tasse JC; Winkens B; Olde Damink SWM; van der Leij C; Schadde E; van Dam RM;
Br J Surg; 2024 Apr; 111(4):. PubMed ID: 38662462
[TBL] [Abstract] [Full Text] [Related]
10. Feasibility Study of Computed Tomographic Radiomics Model for the Prediction of Early and Intermediate Stage Hepatocellular Carcinoma Using BCLC Staging.
Dong H; Yang L; Shaofeng D; Lili G
Technol Cancer Res Treat; 2024; 23():15330338241245943. PubMed ID: 38660703
[TBL] [Abstract] [Full Text] [Related]
11. Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials.
Roller A; Davydov II; Schwalie PC; Serrano-Serrano ML; Heller A; Staedler N; Ferreira CS; Dietmann G; Klaman I; Valdeolivas A; Korski K; Cannarile MA
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38649280
[TBL] [Abstract] [Full Text] [Related]
12. [Exploration and validation of optimal cut-off values for tPSA and fPSA/tPSA screening of prostate cancer at different ages].
Liu XM; Duan HY; Zhang DQ; Chen C; Ji YT; Zhang YM; Feng ZW; Liu Y; Li JJ; Zhang Y; Li CY; Zhang YC; Yang L; Lyu ZY; Song FF; Song FJ; Huang YB
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):354-364. PubMed ID: 38644271
[No Abstract] [Full Text] [Related]
13. [cancer survival analysis in Tianjin, 2010 to 2016].
Wang C; Shen CF; Xun LN; Zhang S; Zhang H; Zheng WL; Wang DZ
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):319-325. PubMed ID: 38644267
[No Abstract] [Full Text] [Related]
14. [Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database].
Zhao YM; Wang WH; Zhang W; Wang L; Li S; Wang JW; Liao LE; Yu GY; Sun Z; Qu YL; Gong Y; Lu Y; Wu T; Li YF; Wang Q; Zhao GH; Xiao Y; Ding PR; Zhang Z; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):372-382. PubMed ID: 38644243
[No Abstract] [Full Text] [Related]
15. ICG-Fluorescence Imaging for Margin Assessment During Minimally Invasive Colorectal liver Metastasis Resection.
Achterberg FB; Bijlstra OD; Slooter MD; Sibinga Mulder BG; Boonstra MC; Bouwense SA; Bosscha K; Coolsen MME; Derksen WJM; Gerhards MF; Gobardhan PD; Hagendoorn J; Lips D; Marsman HA; Zonderhuis BM; Wullaert L; Putter H; Burggraaf J; Mieog JSD; Vahrmeijer AL; Swijnenburg RJ;
JAMA Netw Open; 2024 Apr; 7(4):e246548. PubMed ID: 38639939
[TBL] [Abstract] [Full Text] [Related]
16. Impact of influenza related hospitalization in Spain: characteristics and risk factor of mortality during five influenza seasons (2016 to 2021).
Ramos-Rincón JM; Pinargote-Celorio H; González-de-la-Aleja P; Sánchez-Payá J; Reus S; Rodríguez-Díaz JC; Merino E
Front Public Health; 2024; 12():1360372. PubMed ID: 38628848
[TBL] [Abstract] [Full Text] [Related]
17. HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study.
Chang X; Li X; Sun P; Li Z; Sun P; Ning S
BMC Cancer; 2024 Apr; 24(1):480. PubMed ID: 38627684
[TBL] [Abstract] [Full Text] [Related]
18. Assessment of disease control rate and safety of sorafenib in targeted therapy for advanced liver cancer.
Zeng D; Yu C; Chen S; Zou L; Chen J; Xu L
World J Surg Oncol; 2024 Apr; 22(1):93. PubMed ID: 38605359
[TBL] [Abstract] [Full Text] [Related]
19. Lifestyle factors, glycemic traits, and lipoprotein traits and risk of liver cancer: a Mendelian randomization analysis.
Zhang H; Liu J
Sci Rep; 2024 Apr; 14(1):8502. PubMed ID: 38605235
[TBL] [Abstract] [Full Text] [Related]
20. Design, synthesis, biological assessment and molecular modeling studies of novel imidazothiazole-thiazolidinone hybrids as potential anticancer and anti-inflammatory agents.
Kamboj P; Anjali ; Imtiyaz K; Rizvi MA; Nath V; Kumar V; Husain A; Amir M
Sci Rep; 2024 Apr; 14(1):8457. PubMed ID: 38605072
[TBL] [Abstract] [Full Text] [Related]
[Next]
